Pacific Biosciences Of California | PACB - Current Liabilities


Pacific Biosciences Of California reported $66.59M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Agilent USD 2.29B 20M Jun/2026
Bruker USD 1.17B 32.6M Sep/2026
Danaher USD 9.05B 945M Sep/2026
General Electric Aerospace USD 42.4B 1.96B Sep/2026
Illumina USD 1.16B 422M Sep/2026
Myriad Genetics USD 130.7M 500K Jun/2026
Pacific Biosciences Of California USD 66.59M 2.21M Sep/2026
Quidel USD 1.07B 73.7M Sep/2026
Revvity USD 701.48M 574.88M Sep/2026
Roche Holding CHF 28.85B 846M Jun/2026
Standard Biotools USD 51.02M 5.78M Sep/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Waters USD 2.4B 126M Jun/2026